Liat Bird
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
-
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
Papers in
-
- Protein Degradation and Inhibitors 2
- RNA and protein synthesis mechanisms 1
-
- Chronic Myeloid Leukemia Treatments 3
- Acute Myeloid Leukemia Research 2
- Co-authors
- Nadja Kopp (9 shared papers)David M. Weinstock (9 shared papers)Scott J. Rodig (5 shared papers)Ronald M. Paranal (3 shared papers)Teresa V. Bowman (3 shared papers)James E. Bradner (1 shared paper)Jun Qi (3 shared papers)Christopher J. Ott (2 shared papers)
- Journals
- Blood (6 papers)PLoS ONE (2 papers)European Journal of Cancer (1 paper)Cancer Research (1 paper)mHealth (1 paper)
- Partner nations
- United StatesGermanyVietnam
In The Last Decade
Liat Bird
10 papers receiving 463 citations
Peers
Comparison fields: 5 of 56
- Hematology 154
- Molecular Biology 312
- Genetics 38
- Oncology 88
- Pathology and Forensic Medicine 43
Countries citing papers authored by Liat Bird
This map shows the geographic impact of Liat Bird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liat Bird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liat Bird more than expected).
Fields of papers citing papers by Liat Bird
This network shows the impact of papers produced by Liat Bird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liat Bird. The network helps show where Liat Bird may publish in the future.
Co-authors
The 25 scholars most cited alongside Liat Bird, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 307 | |
| 2 | 2012 | 48 | |
| 3 | 2012 | 36 | |
| 4 | 2016 | 31 | |
| 5 | 2016 | 25 | |
| 6 | 2019 | 8 | |
| 7 | 2012 | 5 | |
| 8 | 2011 | 4 | |
| 9 | 2014 | 4 | |
| 10 | 2012 | 1 | |
| 11 | 2012 | 0 |
About Liat Bird
Liat Bird is a scholar working on Molecular Biology, Hematology, Genetics, Pathology and Forensic Medicine and General Health Professions, having authored 11 papers that have together received 469 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Acute Myeloid Leukemia Research (2 papers), Galectins and Cancer Biology (2 papers), Protein Degradation and Inhibitors (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Mobile Health and mHealth Applications (2 papers) and RNA and protein synthesis mechanisms (1 paper). The work is most often cited by research in Hematology (154 citations), Molecular Biology (312 citations), Genetics (38 citations), Oncology (88 citations) and Pathology and Forensic Medicine (43 citations). Liat Bird has collaborated with scholars based in United States, Germany and Vietnam. Frequent co-authors include Nadja Kopp, David M. Weinstock, Scott J. Rodig, Ronald M. Paranal, Teresa V. Bowman, James E. Bradner, Jun Qi, Christopher J. Ott, Andrew L. Kung and Oliver Weigert. Their work appears in journals such as Blood, PLoS ONE, European Journal of Cancer, Cancer Research and mHealth.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.